Repligen (RGEN) Peer Comparison
$168.48
$-9.72
(-5.45%)
As on 05-Nov-2026 16:00EST
Market cap
$11,234 Mln
Revenue (TTM)
$806 Mln
P/E Ratio
--
P/B Ratio
5.4
Div. Yield
0 %
Edit
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
11,234 | 12,682 | 10,876 | 14,302 | 5,149 |
Revenue ($ Mln) |
806 | 1,560 | 6,636 | 690 | 1,611 |
Net Profit ($ Mln) |
-11.80 | 157.02 | 337.20 | -169.80 | 160.12 |
Net Margin (%) |
-1.47 | 10.06 | 5.08 | -24.60 | 9.94 |
RoE (%) |
-0.56 | 10.27 | 5.90 | -24.46 | 9.50 |
Price to Earnings |
-- | 79.11 | 32.10 | -- | 32.30 |
Price-To-Book |
5.37 | 8.19 | 1.94 | 20.01 | 2.96 |
Income Statement ($ Mln)
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
805.61 | 1,560.33 | 6,635.60 | 690.33 | 1,611.15 |
|
Cost of Revenue
|
394.34 | 499.55 | 4,539.20 | 130.29 | 815.11 |
|
Gross Profit
|
347.62 | 942.44 | 2,139.40 | 393.22 | 736.94 |
|
Operating Expenses
|
392.34 | 871.54 | 1,593.70 | 623.34 | 578.68 |
|
Operating Profit (EBIT)
|
18.93 | 189.25 | 502.70 | -63.30 | 217.37 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
8.23 | 207.82 | 315.50 | -174.52 | 211.71 |
|
Provision for Tax
|
20.03 | 50.81 | -21.70 | -4.72 | 51.59 |
|
Profit after Tax (Net Income)
|
-11.80 | 157.02 | 337.20 | -169.80 | 160.12 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 47.34 | 0.00 | 0.00 | 0.00 |
Liabilities ($ Mln)
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,091.74 | 1,583.51 | 5,835.90 | 717.27 | 1,744.55 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
708.99 | 207.78 | 4,425.10 | 135.53 | 915.27 |
|
Current Liabilities
|
125.69 | 233.81 | 1,369.00 | 126.73 | 265.08 |
|
Total Liabilities
|
2,949.70 | 1,826.52 | 11,794.70 | 893.49 | 2,685.92 |
Assets ($ Mln)
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,684.42 | 648.47 | 9,037.40 | 399.88 | 1,726.09 |
|
Current Assets
|
1,241.98 | 1,376.63 | 2,592.60 | 579.65 | 1,198.82 |
|
Total Assets
|
2,949.70 | 1,826.52 | 11,794.70 | 893.49 | 2,685.92 |
|
Total Debt*
|
692.24 | 209.39 | 3,683.80 | 101.98 | 822.06 |
|
Net Current Assets
|
0.00 | 0.00 | 1,223.60 | 452.92 | 0.00 |
Cashflow ($ Mln)
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
117.42 | 238.66 | 623.80 | -46.34 | 297.37 |
|
Cash Flow from Investing Activities
|
-298.47 | -404.59 | -130.50 | -77.61 | -247.39 |
|
Cash from Financing Activities
|
-15.21 | 26.53 | -409.40 | 11.89 | 16.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
1.79 | 11.76 | -5.43 | -22.53 | 5.52 |
|
ROE (%)
|
-0.56 | 10.27 | 5.90 | -24.46 | 9.50 |
|
ROA (%)
|
-0.33 | 5.91 | 2.57 | -15.48 | 4.58 |
|
EBIT Margin (%)
|
4.20 | 13.40 | 7.39 | -24.51 | 15.15 |
|
Net Margin (%)
|
-1.47 | 10.06 | 5.08 | -24.60 | 9.94 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
13.80 | 16.98 | 0.92 | 46.94 | 9.18 |
|
EBIT Growth (%)
|
29.47 | 11.72 | 106.97 | -106.70 | 34.75 |
|
Net Profit Growth (%)
|
-779.17 | -4.27 | 510.22 | -93.80 | 35.20 |
|
EPS Growth (%)
|
-910.66 | -4.95 | 507.22 | -90.00 | 36.33 |
|
Book Value Growth (%)
|
0.35 | 15.61 | 4.89 | -12.58 | 13.20 |
Valuation Ratios
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
189.42 | 68.93 | -14.68 | -34.59 | 41.18 |
|
Price / Book Value
|
4.40 | 8.58 | 1.40 | 9.90 | 3.34 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
50.32 | 53.25 | 81.94 | -43.50 | 17.29 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.63 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
|
Current Ratio
|
9.88 | 5.89 | 1.89 | 4.57 | 4.52 |
|
Quick Ratio
|
8.43 | 3.92 | 1.27 | 4.09 | 3.05 |
|
Interest Coverage
|
1.24 | 165.16 | 2.81 | -35.23 | 7.55 |
Operating Efficiency Ratios
| Repligen (RGEN) | Penumbra (PEN) | Avantor (AVTR) | Glaukos Corp (GKOS) | Merit Medical Systems (MMSI) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.77 | 12.51 | 16.92 | 21.73 | 16.12 |
|
Asset Turnover
|
0.22 | 0.59 | 0.51 | 0.63 | 0.46 |
|
Receivable days
|
72.41 | 46.54 | 58.79 | 60.95 | 52.18 |
|
Inventory Days
|
146.53 | 331.92 | 64.13 | 193.84 | 150.22 |
|
Payable days
|
29.05 | 26.16 | 58.13 | 60.19 | 30.30 |
|
Cash Conversion Cycle
|
189.88 | 352.30 | 64.79 | 194.60 | 172.09 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
